Text Size

Review of Multimodality Management of Anaplastic Thyroid Cancer

This study has been completed.
Sponsor:
Information provided by:
Alberta Health Services
ClinicalTrials.gov Identifier:
NCT00280852
First received: January 20, 2006
Last updated: November 18, 2011
Last verified: July 2011
History of Changes
  Purpose

To describe the outcome of patients with anaplastic thyroid cancer treated with hyperfractionated radiotherapy and concomitant chemotherapy


Condition
Anaplastic Thyroid Cancer

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: A Retrospective Review of Multimodality Management of Anaplastic Thyroid Cancer

Resource links provided by NLM:

Drug Information available for: Thyroid
U.S. FDA Resources

Further study details as provided by Alberta Health Services:

Enrollment: 5
Study Start Date: January 2006
Study Completion Date: June 2006
Primary Completion Date: June 2006 (Final data collection date for primary outcome measure)
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

anaplastic thyroid cancer

Criteria

Inclusion Criteria:

  • anaplastic thyroid cancer treated with multimodality treatment

Exclusion Criteria:

  • differentiated thyroid cancer
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00280852

Locations
Canada, Alberta
Tom Baker Cancer Centre
Calgary, Alberta, Canada, T2N 4N2
Sponsors and Collaborators
Alberta Health Services
Investigators
Principal Investigator: Harold Lau, MD Alberta Cancerboard
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00280852     History of Changes
Other Study ID Numbers: 18940
Study First Received: January 20, 2006
Last Updated: November 18, 2011
Health Authority: Canada: Health Canada

Keywords provided by Alberta Health Services:
anaplastic thyroid cancer
chemotherapy
radiotherapy

Additional relevant MeSH terms:
Thyroid Neoplasms
Thyroid Diseases
Endocrine Gland Neoplasms
Neoplasms by Site
 Neoplasms
Head and Neck Neoplasms
Endocrine System Diseases

ClinicalTrials.gov processed this record on June 18, 2013